BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 26095896)

  • 1. Factors associated with successful bilateral sentinel lymph node mapping in endometrial cancer.
    Tanner EJ; Sinno AK; Stone RL; Levinson KL; Long KC; Fader AN
    Gynecol Oncol; 2015 Sep; 138(3):542-7. PubMed ID: 26095896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of colorimetric versus fluorometric sentinel lymph node mapping during robotic surgery for endometrial cancer.
    Sinno AK; Fader AN; Roche KL; Giuntoli RL; Tanner EJ
    Gynecol Oncol; 2014 Aug; 134(2):281-6. PubMed ID: 24882555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
    Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
    Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm.
    Hagen B; Valla M; Aune G; Ravlo M; Abusland AB; Araya E; Sundset M; Tingulstad S
    Gynecol Oncol; 2016 Dec; 143(3):479-483. PubMed ID: 27776838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
    Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
    Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of robotic sentinel lymph node detection (RSLND) for patients with endometrial cancer (EC).
    Desai PH; Hughes P; Tobias DH; Tchabo N; Heller PB; Dise C; Slomovitz BM
    Gynecol Oncol; 2014 Nov; 135(2):196-200. PubMed ID: 25175452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of sentinel lymph nodes in patients with endometrial cancer undergoing robotic-assisted staging: a comparison of colorimetric and fluorescence imaging.
    Holloway RW; Bravo RA; Rakowski JA; James JA; Jeppson CN; Ingersoll SB; Ahmad S
    Gynecol Oncol; 2012 Jul; 126(1):25-9. PubMed ID: 22507531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robotic blue-dye sentinel lymph node detection for endometrial cancer - Factors predicting successful mapping.
    Eitan R; Sabah G; Krissi H; Raban O; Ben-Haroush A; Goldschmit C; Levavi H; Peled Y
    Eur J Surg Oncol; 2015 Dec; 41(12):1659-63. PubMed ID: 26433709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Utility of Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer.
    Tanner EJ; Ojalvo L; Stone RL; Levinson K; Temkin SM; Murdock T; Vang R; Sinno AK; Fader AN
    Int J Gynecol Cancer; 2017 Sep; 27(7):1416-1421. PubMed ID: 30814241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FIGO stage IIIC endometrial cancer identification among patients with complex atypical hyperplasia, grade 1 and 2 endometrioid endometrial cancer: laparoscopic indocyanine green sentinel lymph node mapping versus frozen section of the uterus, why get around the problem?
    Papadia A; Gasparri ML; Siegenthaler F; Imboden S; Mohr S; Mueller MD
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):491-497. PubMed ID: 27834005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis.
    Holloway RW; Gupta S; Stavitzski NM; Zhu X; Takimoto EL; Gubbi A; Bigsby GE; Brudie LA; Kendrick JE; Ahmad S
    Gynecol Oncol; 2016 May; 141(2):206-210. PubMed ID: 26905211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel Lymph Node Mapping With Near-Infrared Fluorescent Imaging Using Indocyanine Green: A New Tool for Laparoscopic Platform in Patients With Endometrial and Cervical Cancer.
    Buda A; Bussi B; Di Martino G; Di Lorenzo P; Palazzi S; Grassi T; Milani R
    J Minim Invasive Gynecol; 2016 Feb; 23(2):265-9. PubMed ID: 26455525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic Sentinel Node Mapping in Endometrial Cancer After Hysteroscopic Injection of Indocyanine Green.
    Martinelli F; Ditto A; Bogani G; Signorelli M; Chiappa V; Lorusso D; Haeusler E; Raspagliesi F
    J Minim Invasive Gynecol; 2017 Jan; 24(1):89-93. PubMed ID: 27725278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer.
    How J; Gotlieb WH; Press JZ; Abitbol J; Pelmus M; Ferenczy A; Probst S; Gotlieb R; Brin S; Lau S
    Gynecol Oncol; 2015 Jun; 137(3):436-42. PubMed ID: 25870917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel node mapping with indocyanine green and endoscopic near-infrared fluorescence imaging in endometrial cancer. A pilot study and review of the literature.
    Plante M; Touhami O; Trinh XB; Renaud MC; Sebastianelli A; Grondin K; Gregoire J
    Gynecol Oncol; 2015 Jun; 137(3):443-7. PubMed ID: 25771495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel Node Mapping Using Indocyanine Green and Near-infrared Fluorescence Imaging Technology for Uterine Malignancies: Preliminary Experience With the Da Vinci Xi System.
    Siesto G; Romano F; Fiamengo B; Vitobello D
    J Minim Invasive Gynecol; 2016; 23(4):470-1. PubMed ID: 26767824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of empty lymph node packets in sentinel lymph node mapping for endometrial cancer using indocyanine green.
    Thomaier L; Jager L; Stone R; Wethington S; Fader A; Tanner EJ
    Int J Gynecol Cancer; 2019 Mar; 29(3):513-517. PubMed ID: 30833439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes.
    Barlin JN; Khoury-Collado F; Kim CH; Leitao MM; Chi DS; Sonoda Y; Alektiar K; DeLair DF; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2012 Jun; 125(3):531-5. PubMed ID: 22366409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node biopsy with cervical injection of indocyanine green in apparent early-stage endometrial cancer: predictors of unsuccessful mapping.
    Tortorella L; Casarin J; Multinu F; Cappuccio S; McGree ME; Weaver AL; Langstraat CL; Keeney GL; Kumar A; Melis GB; Angioni S; Scambia G; Mariani A; Glaser GE
    Gynecol Oncol; 2019 Oct; 155(1):34-38. PubMed ID: 31402166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing Single-Site and Multiport Robotic Hysterectomy with Sentinel Lymph Node Mapping for Endometrial Cancer: Surgical Outcomes and Cost Analysis.
    Moukarzel LA; Sinno AK; Fader AN; Tanner EJ
    J Minim Invasive Gynecol; 2017; 24(6):977-983. PubMed ID: 28599884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.